A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough

Clinical trial NCT03979638 · TERMINATED

Trial details

NCT number: NCT03979638
Sponsor: Bellus Health Inc. - a GSK company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Refractory Cough

Start date: 2019-07-10
Primary completion: 2020-04-23
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.